Future of PFS injection devices from cross-industry expertise perspectives – discussion this June in San Diego Read more
Once-daily Trelegy Ellipta gains expanded indication in the US for the treatment of patients with COPD Read more
ADC Therapeutics Announces the Termination of its ADCT-502 Program Targeting HER2 Expressing Solid Tumors Read more
Grand River Aseptic Manufacturing Expands Pharmaceutical Manufacturing Capacity with Major Equipment Purchase Read more